You are here:


57. Eriksen JG, Salembier C, Rivera S, De Bari B, Berger D, Mantello G et al. Four years with FALCON - an ESTRO educational project: achievements and perspectives. Radiother Oncol. 2014 Jul;112(1):145-9.

56. Dunscombe P, Grau C, Defourny N, Malicki J, Borras JM, Coffey M, Bogusz M et al Guidelines for equipment and staffing of radiotherapy facilities in the European countries: final results of the ESTRO-HERO survey. Radiother Oncol. 2014 Aug;112(2):165-77.

55. Due AK, Vogelius IR, Aznar MC, Bentzen SM, Berthelsen AK, Korreman SS, Loft A, Kristensen CA, Specht L. Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake. Radiother Oncol. 2014 Jun;111(3):360-5.

54. Fledelius W, Worm E, Høyer M, Grau C, Poulsen PR. Real-time segmentation of multiple implanted cylindrical liver markers in kilovoltage and megavoltage x-ray images. Phys Med Biol. 2014 Jun 7;59(11):2787-800.

53. Hansen DC, Petersen JB, Bassler N, Sørensen TS. Improved proton computed tomography by dual modality image reconstruction. Med Phys. 2014 Mar;41(3):031904.

52. Sander L, Langkilde NC, Holmberg M, Carl J. MRI target delineation may reduce long-term toxicity after prostate radiotherapy. Acta Oncol. 2014 Jun;53(6):809-14.

51. Schmidt ML, Poulsen PR, Toftegaard J, Hoffmann L, Hansen D, Sørensen TS. Clinical use of iterative 4D-cone beam computed tomography reconstructions to investigate respiratory tumor motion in lung cancer patients. Acta Oncol. 2014 Aug;53(8):1107-13.

50. Poulsen PR, Worm ES, Petersen JB, Grau C, Fledelius W, Høyer M. Kilovoltage intrafraction motion monitoring and target dose reconstruction for stereotactic volumetric modulated arc therapy of tumors in the liver. Radiother Oncol. 2014 Jun;111(3):424-30.

49. Ravkilde T, Keall PJ, Grau C, Høyer M, Poulsen PR. Fast motion-including dose error reconstruction for VMAT with and without MLC tracking. Phys Med Biol. 2014 Dec 7;59(23):7279-96.

48. Toftegaard J, Fledelius W, Seghers D, Huber M, Brehm M, Worm ES, Elstrøm UV, Poulsen PR. Moving metal artifact reduction in cone-beam CT scans with implanted cylindrical gold markers. Med Phys. 2014 Dec;41(12):121710.

47. Thor M, Andersen ES, Petersen JB, Sørensen TS, Noe KØ, Tanderup K, Bentzen L, Elstrøm UV, Høyer M, Muren LP. Evaluation of an application for intensity-based deformable image registration and dose accumulation in radiotherapy. Acta Oncol. 2014 Oct;53(10):1329-36.

46. Vestergaard A, Muren LP, Lindberg H, Jakobsen KL, Petersen JB, Elstrøm UV, Agerbæk M, Høyer M. Normal tissue sparing in a phase II trial on daily adaptive plan selection in radiotherapy for urinary bladder cancer. Acta Oncol. 2014 Aug;53(8):997-1004.

45. Casares-Magaz O, Toftegaard J, Muren LP, Kallehauge JF, Bassler N, Poulsen PR, Petersen JB. A method for selection of beam angles robust to intra-fractional motion in proton therapy of lung cancer. Acta Oncol. 2014 Aug;53(8):1058-63.

44. Elstrøm UV, Olsen SR, Muren LP, Petersen JB, Grau C. The impact of CBCT reconstruction and calibration for radiotherapy planning in the head and neck region - a phantom study. Acta Oncol. 2014 Aug;53(8):1114-24.

43. Søndergaard J, Holmberg M, Jakobsen AR, Agerbæk M, Muren LP, Høyer M. A comparison of morbidity following conformal versus intensity-modulated radiotherapy for urinary bladder cancer. Acta Oncol. 2014 Oct;53(10):1321-8.

42. Stokkevåg CH, Engeseth GM, Ytre-Hauge KS, Röhrich D, Odland OH, Muren LP, Brydøy M, Hysing LB, Szostak A, Palmer MB, Petersen JB. Estimated risk of radiation-induced cancer following paediatric cranio-spinal irradiation with electron, photon and proton therapy. Acta Oncol. 2014 Aug;53(8):1048-57.

41. Muren LP, Teräs M, Knuuti J. NACP 2014 and the Turku PET symposium: the interaction between therapy and imaging. Acta Oncol. 2014 Aug;53(8):993-6.

40. Vestergaard A, Kallehauge JF, Petersen JB, Høyer M, Søndergaard J, Muren LP. An adaptive radiotherapy planning strategy for bladder cancer using deformation vector fields. Radiother Oncol. 2014 Sep;112(3):371-5.

39. Schytte T, Nielsen TB, Brink C, Hansen O. Pattern of loco-regional failure after definitive radiotherapy for non-small cell lung cancer. Acta Oncol. 2014 Mar;53(3):336-41.

38. Brink C, Bernchou U, Bertelsen A, Hansen O, Schytte T, Bentzen SM. Locoregional control of non-small cell lung cancer in relation to automated early assessment of tumor regression on cone beam computed tomography. Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):916-23.

37. Lorenzen EL, Ewertz M, Brink C. Automatic segmentation of the heart in radiotherapy for breast cancer. Acta Oncol. 2014 Oct;53(10):1366-72.

36. Skripcak T, Belka C, Bosch W, Brink C, Brunner T, Budach V, Büttner D, Debus J, Dekker A, Grau C, Gulliford S, Hurkmans C, Just U, Krause M, Lambin P, Langendijk JA, Lewensohn R, Lühr A, Maingon P, Masucci M, Niyazi M, Poortmans P, Simon M, Schmidberger H, Spezi E, Stuschke M, Valentini V, Verheij M, Whitfield G, Zackrisson B, Zips D, Baumann M. Creating a data exchange strategy for radiotherapy research: towards federated databases and anonymised public datasets. Radiother Oncol. 2014 Dec;113(3):303-9.

35. Baumann M, Overgaard J. What next? Radiother Oncol. 2014 Jan;110(1):1-2.

33. Tramm T, Mohammed H, Myhre S, Kyndi M, Alsner J, Børresen-Dale AL, Sørlie T, Frigessi A, Overgaard J. Development and validation of a gene profile predicting benefit of postmastectomy radiotherapy in patients with high-risk breast cancer: a study of gene expression in the DBCG82bc cohort. Clin Cancer Res. 2014 Oct 15;20(20):5272-80.

32. Sørensen BS, Busk M, Horsman MR, Alsner J, Overgaard J, Kyle AH, Minchinton AI. Effect of radiation on cell proliferation and tumor hypoxia in HPV-positive head and neck cancer in vivo models. Anticancer Res. 2014 Nov;34(11):6297-304.

31. Lassen P, Primdahl H, Johansen J, Kristensen CA, Andersen E, Andersen LJ, Evensen JF, Eriksen JG, Overgaard J; Danish Head and Neck Cancer Group (DAHANCA). Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer. Radiother Oncol. 2014 Dec;113(3):310-6.

30. Søes S, Daugaard IL, Sørensen BS, Carus A, Mattheisen M, Alsner J, Overgaard J, Hager H, Hansen LL, Kristensen LS. Hypomethylation and increased expression of the putative oncogene ELMO3 are associated with lung cancer development and metastases formation. Oncoscience. 2014 May 23;1(5):367-74.

29. Hansen DC, Bassler N, Sørensen TS, Seco J. The image quality of ion computed tomography at clinical imaging dose levels. Med Phys. 2014 Nov;41(11):111908.

28. N. Bassler, D. C. Hansen, A. Lühr, B. Thomsen, J. B. Petersen, N. Sobolevsky SHIELD-HIT12A - a Monte Carlo particle transport program for ion therapy research Journal of Physics Conference Series 02/2014; 489(1).

27. Aznar MC, Persson GF, Kofoed IM, Nygaard DE, Korreman SS. Irregular breathing during 4DCT scanning of lung cancer patients: is the midventilation approach robust? Phys Med. 2014 Feb;30(1):69-75.

26. Fokdal L, Ørtoft G, Hansen ES, Røhl L, Pedersen EM, Tanderup K, Lindegaard JC. Toward four-dimensional image-guided adaptive brachytherapy in locally recurrent endometrial cancer. Brachytherapy. 2014 Nov-Dec;13(6):554-61.

25. Appelt AL, Vogelius IR, Pløen J, Rafaelsen SR, Lindebjerg J, Havelund BM, Bentzen SM, Jakobsen A. Long-term results of a randomized trial in locally advanced rectal cancer: no benefit from adding a brachytherapy boost. 2014

24. Aggerholm-Pedersen N, Safwat A, Bærentzen S, Nordsmark M, Nielsen OS, Alsner J, Sørensen BS. The importance of reference gene analysis of formalin-fixed, paraffin-embedded samples from sarcoma patients - an often underestimated problem. Transl Oncol. 2014 Dec;7(6):687-93.

23. Tanderup K, Viswanathan AN, Kirisits C, Frank SJ. Magnetic Resonance Image Guided Brachytherapy. Semin Radiat Oncol. 2014 Jul;24(3):181-191.

22. Assenholt MS, Vestergaard A, Kallehauge JF, Mohamed S, Nielsen SK, Petersen JB, Fokdal L, Lindegaard JC, Tanderup K. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer. Brachytherapy. 2014 Jul-Aug;13(4):361-8.

21. Nygren MK, Tekle C, Ingebrigtsen VA, Mäkelä R, Krohn M, Aure MR, Nunes-Xavier CE, Perälä M, Tramm T, Alsner J, Overgaard J, Nesland JM, Borgen E, Børresen-Dale AL, Fodstad Ø, Sahlberg KK, Leivonen SK. Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c. Br J Cancer. 2014 Apr 15;110(8):2072-80.

20. Bøje CR, Dalton SO, Primdahl H, Kristensen CA, Andersen E, Johansen J, Andersen LJ, Overgaard J. Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database. Radiother Oncol. 2014 Jan;110(1):91-7

18. Quigley DA, Fiorito E, Nord S, Van Loo P, Alnæs GG, Fleischer T, Tost J, Moen Vollan HK, Tramm T, Overgaard J, Bukholm IR, Hurtado A, Balmain A, Børresen-Dale AL, Kristensen V1 The 5p12 breast cancer susceptibility locus affects MRPS30 expression in estrogen-receptor positive tumors. Mol Oncol. 2014 Mar;8(2):273-84

17. Deasy JO, Muren LP. Advancing our quantitative understanding of radiotherapy normal tissue morbidity. Acta Oncol. 2014 May;53(5):577-9.

16. Grantzau T, Thomsen MS, Væth M, Overgaard J. Risk of second primary lung cancer in women after radiotherapy for breast cancer. Radiother Oncol. 2014 Jun;111(3):366-73.

15. Malinen E, Muren LP. Image guided therapy - do we get the picture? Acta Oncol. 2014 Jan;53(1):3-5.

13. Ringbæk TP, Weber U, Petersen JB, Thomsen B, Bassler N. Monte Carlo simulations of new 2D ripple filters for particle therapy facilities. Acta Oncol. 2013 Sep 20.

12. Hansen CR, Christiansen RL, Nielsen TB, Bertelsen AS, Johansen J, Brink C. Comparison of three immobilisation systems for radiation therapy in head and neck cancer. Acta Oncol. 2013 Sep 24.

11. Grégoire V, Ang K, Budach W, Grau C, Hamoir M, Langendijk JA, Lee A, Le QT, Maingon P, Nutting C, O'Sullivan B, Porceddu SV, Lengele B. Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiother Oncol. 2013 Oct 31.

10. Thörnqvist S, Hysing LB, Zolnay AG, Söhn M, Hoogeman MS, Muren LP, Bentzen L, Heijmen BJ. Treatment simulations with a statistical deformable motion model to evaluate margins for multiple targets in radiotherapy for high-risk prostate cancer. Radiother Oncol. 2013 Oct 31.

9. Tramm T, Hennig G, Kyndi M, Alsner J, Sørensen FB, Myhre S, Sørlie T, Overgaard J. Reliable PCR quantitation of estrogen, progesterone and ERBB2 receptor mRNA from formalin-fixed, paraffin-embedded tissue is independent of prior macro-dissection. Virchows Arch. 2013 Oct 8.

7. Vogelius IR, Håkansson K, Due AK, Aznar MC, Berthelsen AK, Kristensen CA, Rasmussen J, Specht L, Bentzen SM. Failure-probability driven dose painting. Med Phys. 2013 Aug;40(8)

6. Appelt AL, Vogelius IR, Farr KP, Khalil AA, Bentzen SM. Towards individualized dose constraints: Adjusting the QUANTEC radiation pneumonitis model for clinical risk factors. Acta Oncol. 2014 May;53(5):605-12.

5. Bassler N, Toftegaard J, Lühr A, Sørensen BS, Scifoni E, Krämer M, Jäkel O, Mortensen LS, Overgaard J, Petersen JB. LET-painting increases tumour control probability in hypoxic tumours. Acta Oncol. 2014 Jan;53(1):25-32.

1. Lühr A, Priegnitz M, Fiedler F, Sobolevsky N, Bassler N. Dependence of simulated positron emitter yields in ion beam cancer therapy on modeling nuclear fragmentation. Appl Radiat Isot. 2013 Jan 3.